EDITORIAL SECTION

Articles

Next-Gen Continuous Biomanufacturing: Redefining Efficiency and Quality Standards

Continuous biomanufacturing represents a paradigm shift in the production of biopharmaceuticals offering unparalleled efficiency flexibility and quality control compared to traditional batch processes

Breaking Down Barriers: Advancements in Biodegradable Drug Delivery

In todays world where sustainability is a top priority breaking down barriers to a greener future is crucial One area where advancements are being made is in the field of biodegradable drug delivery

How Quantum Computing Is Transforming Drug Discovery

The current medical setting sees technology lead drug development towards faster speeds Quantum computing in drug discovery belongs to an exclusive group of technological advances that drives revolutionary change in science The advanced computational model called quantum computing drives innovation in drug discovery as well as drug testing and pharmaceutical market release Scientists and experts n...

Biopharma M&A and Licensing: Strategic Partnerships Fueling Innovation

For much of the last decade acquisitions and licensing agreements were debated in European boardrooms as rival answers to the same question how to refill a pipeline faster than internal research alone allows That framing no longer holds In the most effective pharmaceutical companies run both instruments in parallel choosing between them asset by asset according to scientific maturity geographic o...

Emerging Technologies in Automation Machinery for the Pharmaceutical Industry

Pharmaceutical industry has long been a forerunner on the use of technology where it has proved vital in increasing efficiency quality and safety Automation machinery has become more important over the years due to its ability to efficiently handle manufacturing packaging and distribution challenges Advanced technology is improving automation machinery as an integration tool in the pharmaceutical...

Digital Twins in Pharmaceutical R&D: Simulating Biology for Faster Innovation

For most of its modern history pharmaceutical research has been an experimental science with a statistical conscience Build the molecule dose the animal run the trial count the failures and let the survivors pay for everything that did not make it That arrangement has become progressively harder to defend Attrition remains concentrated in the phases where money has already

Techno Trends

Alume Biosciences Secures FDA Breakthrough Therapy Designation for Bevonescein

Alume Biosciences has received Breakthrough Therapy Designation BTD from the US Food and Drug Administration FDA for bevonescein an investigational fluorescent drug being developed to support realtime nerve visualisation during head and neck surgery in adults Bevonescein is an intravenous fluorescent peptidedye conjugate that binds to nerve tissue

Projects

SK pharmteco Plans More Than US$200 Million Investment in Small Molecule and Peptide Manufacturing

SK pharmteco is planning a fiveyear investment of more than US million to expand and modernise its pharmaceutical development and manufacturing operations in the United States The programme will strengthen capabilities for small molecules and peptides while supporting a more

Research Insights

One-month physicochemical stability study of idarubicin prepared in polyolefin-type bags for the treatment of hematological diseases

Idarubicine is a mainstay of the treatment strategy for hematological cancer The literature lacks stability data that comply with current preparation practices and recommendations for conducting stability studies

whitepaper

Post-Translational Modifications in Drug Discovery: From Molecular Regulation to Clinical Impact

For decades the central dogma of molecular biology has anchored our understanding of cellular function DNA to RNA to protein But this linear view is incomplete A growing body of evidence shows that much of biologys